F Kradolfer. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antitubercular Agents/therapeutic useHumansRespiratory Tract Infections/drug therapyRifampin/administration & dosageRifampin/pharmacologyRifampin/therapeutic useStaphylococcal Infections/drug therapyStaphylococcus/drug effectsTuberculosis, Pulmonary/drug therapyUrinary Tract Infections/drug therapy
Substances: See more » Antitubercular AgentsRifampin
Year: 1968 PMID: 5688592
Source DB: PubMed Journal: Schweiz Med Wochenschr ISSN: 0036-7672